DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today announces that it will be presenting brand-new data on ...

A presentation at AONN+ Annual Conference draws a connection between navigation and improved clinical trial accrual and NGS testing adherence.

The global Life Science Instrumentation Market, valued at US$63.4 billion in 2025, is projected to advance at a resilient CAGR of 6.5% ...

Final Phase 1b results presented at World Lung Conference highlight the potential of firmonertinib to address unmet needs in EGFR PACC mutant NSCLC Received FDA IND clearance for ARR-217, a CDH-17 ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

In May 2023, the Human Pangenome Reference Consortium (HPRC) released the first draft of the human pangenome reference ...

The company said that recent study results show its Aventa Lymphoma test can provide actionable information that would typically be missed by FISH testing.

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "bioMerieux SA (BIM) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. This report is an invaluable resource, ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Therma Bright Inc. (THRM) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets's offering.

Q3 2025 Management View Justin Jacobs, CEO, opened by stating, "NGS delivered record results again in the third quarter, extending our momentum and reinforcing the value we provide our customers ...